OPTUS Pharmaceutical Co., Ltd.'s Equity Buyback announced on September 7, 2022 has closed with 463,678 shares, representing 2.97% for KRW 2,944.46 million.
Optus Pharmaceutical Co Ltd, formerly DHP Korea Co Ltd, is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company is primarily engaged in the manufacture and sale of eye drops and ophthalmic preparations such as dry eye treatment agents, conjunctivitis treatment agents, anti-inflammatory medication agents, glaucoma treatment agents and others.
OPTUS Pharmaceutical Co., Ltd.'s Equity Buyback announced on September 7, 2022 has closed with 463,678 shares, representing 2.97% for KRW 2,944.46 million.
marketscreener.com**derivatives**en**/dynamic-chart/**Premium**Expert**Access**Annual**Monthly**-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.**#000000**/services/solutions/**#fff826**#ff3000**#ffffff**BENEFIT NOW**0**linear-gradient(180deg, rgba(42,73,76,1) 0%, rgba(28,30,51,1) 53%);**linear-gradient(180deg, rgba(255, 248, 38,1) 0%, rgba(247, 239,1) 53%);**date_fin_hors_prolongation**49**on all our subscriptions**